Aberrant NK cell associated marker (CD56 and CD57) expression in chronic lymphocytic leukemia

By  

Cytometry. Part B: Clinical Cytometry, Vol. 88, Iss. 5, 2015-09 ,pp. : 348-351

John Wiley & Sons Inc

Access to resources Recommend Favorite

SEMG-1 expression in early stage chronic lymphocytic leukemia

By Ahmed Sharif Uddin   Meklat Farouk   Shahriar Masum   Zhang Jian   Mastulov Suhkrob   Giannakouros Thomas   Jewell Andrew   Zhang Yana   Lim Seah  

Cytotherapy, Vol. 11, Iss. 2, 2009-04 ,pp. : 238-244

Ashgate Publishing Ltd

Access to resources Recommend Favorite

CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma

By  

Cytometry. Part B: Clinical Cytometry, Vol. 94, Iss. 1, 2018-01 ,pp. : 129-135

John Wiley & Sons Inc

Access to resources Recommend Favorite

CD40-ligand/interleukin-2 vaccines in chronic lymphocytic leukemia: the impact of vaccine design

By Rezvani Katayoun  

Cytotherapy, Vol. 13, Iss. 9, 2011-10 ,pp. : 1029-1030

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia

By Okur Fatma Visal   Yvon Eric   Biagi Ettore   Dotti Gianpietro   Carrum George   Heslop Helen   Mims Martha P.   Fratantoni Joseph C.   Peshwa Madhusudan V.   Li Linhong   Brenner Malcolm K.  

Cytotherapy, Vol. 13, Iss. 9, 2011-10 ,pp. : 1128-1139

Ashgate Publishing Ltd

Access to resources Recommend Favorite